D. Wagner

发表

Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies

J. Polli, M. Reese, J. Humphreys, 2012, Drug Metabolism and Disposition.

Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity.

J. Polli, M. R. Groseclose, S. Castellino, 2013, Chemical research in toxicology.

Cardiolipin profiles as a potential biomarker of mitochondrial health in diet‐induced obese mice subjected to exercise, diet‐restriction and ephedrine treatment

Laura Hagerty, C. Elangbam, S. Castellino, 2014, Journal of applied toxicology : JAT.

The Role of Drug Metabolism in Immune-Mediated Drug Toxicity : Molecular , Clinical and Mechanistic Aspects Poster

D. Mansuy, G. Bertho, P. Dansette, 2013 .

MALDI imaging mass spectrometry: bridging biology and chemistry in drug development.

M. R. Groseclose, S. Castellino, Stephen Castellino, 2011, Bioanalysis.

The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys

G. Bowers, E. Kanaoka, D. Wagner, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans

S. Piscitelli, M. Reese, W. Spreen, 2016, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolite structure analysis by high-resolution MS: supporting drug-development studies.

G. Bowers, J. Pirhalla, D. Wagner, 2013, Bioanalysis.

Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir

S. Piscitelli, J. Rubio, D. Wilfret, 2014, European Journal of Clinical Pharmacology.

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

S. Piscitelli, S. Castellino, I. Goljer, 2013, Antimicrobial Agents and Chemotherapy.

Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Co-Transporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance and Ketoconazole Interaction Studies.

J. Polli, J. Humphreys, R. Dobbins, 2012 .